mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |